Oric Pharmaceuticals, Inc. (ORIC) stock
ORICNasdaqPharmaceutical PreparationsFiscal year ends December 31
$7.65−0.35 (-4.37%)
Close on Nov 18, 2026Market cap $792.94MP/E –Yield –
Oric Pharmaceuticals free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Oric Pharmaceuticals's free cash flow for the twelve months ending Jun 30, 2026 was -$112.26M. For fiscal 2025 it was -$111.68M. The highest annual figure on record is -$21.21M in fiscal 2018.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$111.68M | – |
| FY2024 | Dec 31, 2024 | -$113.85M | – |
| FY2023 | Dec 31, 2023 | -$86.54M | – |
| FY2022 | Dec 31, 2022 | -$77.22M | – |
| FY2021 | Dec 31, 2021 | -$60.48M | – |
| FY2020 | Dec 31, 2020 | -$45.94M | – |
| FY2019 | Dec 31, 2019 | -$24.30M | – |
| FY2018 | Dec 31, 2018 | -$21.21M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$31.96M | – |
| Q1 FY2026 | Mar 31, 2026 | -$32.44M | – |
| Q4 FY2025 | Dec 31, 2025 | -$22.71M | – |
| Q3 FY2025 | Sep 30, 2025 | -$25.15M | – |
| Q2 FY2025 | Jun 30, 2025 | -$30.91M | – |
| Q1 FY2025 | Mar 31, 2025 | -$32.92M | – |
| Q4 FY2024 | Dec 31, 2024 | -$28.27M | – |
| Q3 FY2024 | Sep 30, 2024 | -$29.22M | – |
| Q2 FY2024 | Jun 30, 2024 | -$25.96M | – |
| Q1 FY2024 | Mar 31, 2024 | -$30.40M | – |
| Q4 FY2023 | Dec 31, 2023 | -$24.33M | – |
| Q3 FY2023 | Sep 30, 2023 | -$19.72M | – |
| Q2 FY2023 | Jun 30, 2023 | -$21.55M | – |
| Q1 FY2023 | Mar 31, 2023 | -$20.94M | – |
| Q4 FY2022 | Dec 31, 2022 | -$15.62M | – |
| Q3 FY2022 | Sep 30, 2022 | -$19.72M | – |
| Q2 FY2022 | Jun 30, 2022 | -$18.44M | – |
| Q1 FY2022 | Mar 31, 2022 | -$23.44M | – |
| Q4 FY2021 | Dec 31, 2021 | -$16.67M | – |
| Q3 FY2021 | Sep 30, 2021 | -$12.38M | – |
| Q2 FY2021 | Jun 30, 2021 | -$16.35M | – |
| Q1 FY2021 | Mar 31, 2021 | -$15.08M | – |
| Q4 FY2020 | Dec 31, 2020 | -$18.24M | – |
| Q3 FY2020 | Sep 30, 2020 | -$9.63M | – |
| Q2 FY2020 | Jun 30, 2020 | -$9.79M | – |
| Q1 FY2020 | Mar 31, 2020 | -$8.28M | – |
| Q4 FY2019 | Dec 31, 2019 | -$7.20M | – |
| Q3 FY2019 | Sep 30, 2019 | -$5.58M | – |
| Q2 FY2019 | Jun 30, 2019 | -$5.89M | – |
| Q1 FY2019 | Mar 31, 2019 | -$5.63M | – |
See a number that looks wrong?